BETA Technologies to Announce First Quarter 2026 Results on May 12, 2026

BETA Technologies to Announce First Quarter 2026 Results on May 12, 2026

SOUTH BURLINGTON, Vt.–(BUSINESS WIRE)–
BETA Technologies, Inc. (NYSE: BETA) (“BETA” or “the Company”), an electric aerospace company, today announced it will release its financial results for the first quarter of 2026 before the market opens on May 12, 2026. The Company will also host a live webcast beginning at 8:30 a.m. ET to discuss the results.

A live webcast and supporting materials can be accessed here. All participants joining by telephone should register by clicking here for personal dial-in and PIN numbers. For those unable to participate in the live call, a replay will be made available on the Company’s investor relations page.

About BETA Technologies, Inc.

BETA (NYSE: BETA) is an aerospace company designing, manufacturing and selling high-performance electric aircraft, advanced electric propulsion systems, components and charging systems to top operators worldwide. BETA has built and flown its family of ALIA aircraft, consisting of both conventional fixed-wing electric aircraft (the “ALIA CTOL”) and electric vertical takeoff and landing aircraft (the “ALIA VTOL”), more than 130,000 nautical miles, including multiple trips across the United States. BETA is deploying a network of charging infrastructure to enable the growing industry with more than 100 sites across the United States and internationally. BETA’s intentional approach to developing the enabling technologies necessary to electrify aviation unlocks lucrative aftermarket revenue opportunity over the life of each aircraft. These highly scalable enabling technologies allow BETA to serve a customer base across cargo and logistics, defense, passenger and medical end markets and unlock cost-effective and safe missions. BETA was named the #1 company on TIME’s list of the World’s Top GreenTech Companies of 2025. Visit www.beta.team for more information about BETA and its products.

Media:

[email protected]

Investors:

Devon Rothman

[email protected]

KEYWORDS: Vermont United States North America

INDUSTRY KEYWORDS: Engineering Aerospace Manufacturing

MEDIA:

Logo
Logo

Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis 

  • This is the first release of 36-week symptom response & tissue health data for the highest dose (Cohort 9) from the dose escalation portion of Eupraxia’s RESOLVE trial. 
  • At 36 weeks, patients in Cohort 9 (n=3) demonstrated a robust response in both tissue health and symptom response compared to their baseline levels.
  • Patients in Cohort 9 also demonstrated the highest response in tissue health at week 36 compared to all other dose cohorts in the RESOLVE trial.
  • Clinical remission in symptoms was maintained in 66% of the patients (2 of 3) in Cohort 9 at week 36. This level of remission was first achieved at week 8 and was maintained through 36 weeks.
  • EP-104GI continues to be well tolerated by patients receiving the drug; 31 patients have been treated in the Phase 1b/2a study and over 230 patient-months of follow-up have been reported with no drug related Serious Adverse Events (“SAEs”). There still have been no cases of oropharyngeal candidiasis, a commonly reported adverse event with the oral delivery of steroids.

VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced 36-week tissue health and symptom data from patients in the highest dose cohort from its ongoing Phase 1b/2a part of the RESOLVE trial evaluating EP-104GI for the treatment of eosinophilic esophagitis (“EoE”).

“We are very pleased with the robust and sustained response in both tissue health and symptom data in the highest dose cohort at 36 weeks,” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “This data is consistent with the compelling results we observed at earlier timepoints at this dose level, highlighting the potential to achieve both strong and durable responses after a single administration of EP-104GI. We are also reassured by the excellent safety outcomes across all doses in the trial as we continue to observe no indication of drug related SAEs or spikes in glucose or cortisol. We look forward to the results of the placebo-controlled Phase 2b portion of the study where the same dose is being further evaluated”.

Key New Findings from the RESOLVE Trial

Tissue Health Outcomes as Measured by EoEHSS and PEC

  • In Cohort 9 (20 x 8 mg dose) the EoEHSS Stage and Grade reductions at week 36 were 0.59 and 0.53, representing a 90% and 88% reduction, respectively.
  • Notably, improvements were seen across both inflammatory and architectural (i.e. structural) components that comprise the EoEHSS score, suggesting improvements in both inflammatory and fibrotic histologic aspects of the disease.
  • Also in Cohort 9 at week 36, there was a 72% reduction in Peak Eosinophil Count (PEC) from baseline. Compared to all other dose cohorts, this was the largest reduction in PEC.

Clinical Remission and Symptom Response as Measured by SDI

  • In Cohort 9, at week 36 there was an average reduction compared to baseline in the Straumann Dysphagia Index (SDI) of 3 points (a 3-point reduction is defined as clinical remission).
  • In total, 2 of 3 patients maintained clinical remission from weeks 8 to 36, representing a 66% clinical remission response rate.

Safety and Tolerability

  • To date, over 230 patient-months of follow-up have been reported across 31 patients in all cohorts.
  • No drug related SAEs have been reported.
  • No cases of oropharyngeal candidiasis, a commonly reported adverse event associated with the use of swallowed steroids, have been reported.
  • No cases of adrenal insufficiency or glucose derangement, including in the single patient with type II diabetes.
  • EP-104GI has been generally well tolerated at all dose levels, including the highest dose of 8 mg/site at 20 injection sites (Cohort 9).

An updated summary of the above and previously announced clinical trial results are posted in the Investor Section of the Eupraxia Pharmaceuticals website and can be found here.

About the RESOLVE Trial 

The Phase 1b/2a part of the RESOLVE trial is a multicenter, open-label, dose-escalation study evaluating the safety, tolerability, pharmacokinetics, and efficacy of EP-104GI in adults with histologically confirmed active EoE. The treatment is administered as a single dose via 4 to 20 esophageal wall injections, with dose escalations modifying either the dose per site and/or the number of sites. Participants were followed for up to 24 weeks in Cohorts 1-4 (4x1mg, 8x1mg, 8×2.5mg and 12×2.5mg) or 52 weeks in Cohorts 5-9 (12x4mg, 16x4mg, 20x4mg, 20x6mg and 20x8mg). Eupraxia plans to disclose additional data from the open-label Phase 1b/2a part of the RESOLVE trial in the coming months.

The Phase 2b part of RESOLVE trial, a randomized placebo-controlled study of EP-104GI, is currently recruiting both the 120mg (20x6mg) and 160mg (20x8mg) doses. The top-line data from the Phase 2b part of the RESOLVE trial is expected in Q4 2026. 

Notes 

  1. Clinical remission is defined as a reduction of at least 3 points on the SDI scale. Achieving clinical remission is a positive outcome for the RESOLVE trial. 
  2. SDI is a patient-reported outcome score that uses a seven-day recall measuring dysphagia (trouble swallowing) severity and frequency. A reduction in SDI is a positive outcome for the RESOLVE trial. 

About Eosinophilic Esophagitis (EoE) 
EoE is an inflammatory-mediated disease in which white blood cells migrate into and become trapped in the esophagus, creating pain and difficulty with swallowing food. According to market research from Clearview Healthcare Partners, EoE affects more than 450,000 people in the United States and has been identified by the American Gastroenterological Association as rapidly increasing in both incidence and prevalence. Impacts from both symptoms and interventions frequently lead to mental health issues, compounding the disease burden of EoE for both the healthcare system and the individual. 

About Eupraxia Pharmaceuticals Inc. 

Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Diffusphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians are wanting to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the Diffusphere™ technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia’s Diffusphere™ technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, to also be applicable in oncology, infectious disease and other critical disease areas.

Eupraxia’s EP-104GI is currently in a Phase 1b/2 trial, the RESOLVE trial, for the treatment of EoE. EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. This is a unique treatment approach for EoE. Eupraxia also completed a Phase 2b clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. The trial met its primary endpoint and three of the four secondary endpoints. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Company’s website at: www.eupraxiapharma.com.

Notice Regarding Forward-looking Statements and Information 

This news release includes forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “is expected”, “expects”, “suggests”, “indicates”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes”, “potential” or variations (including negative and grammatical variations) of such words and phrases, or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements in this news release include statements regarding the interpretation of the 36-week data from the RESOLVE trial, including tissue health and symptom response; the Company’s expected timing of reporting additional data from the RESOLVE trial, including the Phase 2b portion thereof; the Company’s product candidates, including their expected benefits with respect to safety, tolerability, efficacy and duration of effect and their potential use in therapeutic areas beyond pain and inflammatory gastrointestinal disease; the expectations regarding the advancement of the Company’s product candidates through clinical development; the results of clinical trials of the Company’s product candidates; the potential for the Company’s technology to impact the drug delivery process; the potential market opportunity for the Company’s product candidates; and potential pipeline indications. Such statements and information are based on the current expectations of Eupraxia’s management, and are based on assumptions, including but not limited to: future research and development plans for the Company proceeding substantially as currently envisioned; industry growth trends, including with respect to projected and actual industry sales; the Company’s ability to obtain positive results from the Company’s research and development activities, including clinical trials; and the Company’s ability to protect patents and proprietary rights. Although Eupraxia’s management believes that the assumptions underlying these statements and information are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this news release may not occur by certain dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting Eupraxia, including, but not limited to: risks and uncertainties related to the Company’s limited operating history; the Company’s novel technology with uncertain market acceptance; if the Company breaches any of the agreements under which it licenses rights to its product candidates or technology from third parties, the possibility that the Company could lose license rights that are important to its business; the Company’s current license agreement may not provide an adequate remedy for its breach by the licensor; the possibility that the Company’s technology may not be successful for its intended use; the fact that the Company’s future technology will require regulatory approval, which is costly and the Company may not be able to obtain it; the possibility that the Company may fail to obtain regulatory approvals or only obtain approvals for limited uses or indications; the possibility that the Company’s clinical trials may fail to demonstrate adequately the safety and efficacy of its product candidates at any stage of clinical development; the possibility that the Company may be required to suspend or discontinue clinical trials due to side effects or other safety risks; the fact that the Company completely relies on third parties to provide supplies and inputs required for its product candidates and services; the potential impact of tariffs on the cost of the Company’s active pharmaceutical ingredients and clinical supplies of EP-104IAR and EP-104GI; the fact that the Company relies on external contract research organizations to provide clinical and non-clinical research services; the possibility that the Company may not be able to successfully execute its business strategy; the fact that the Company will require additional financing, which may not be available; the fact that any therapeutics the Company develops will be subject to extensive, lengthy and uncertain regulatory requirements, which could adversely affect the Company’s ability to obtain regulatory approval in a timely manner, or at all; the impact of health pandemics or epidemics on the Company’s operations; the Company’s restatement of its consolidated financial statements, which may lead to additional risks and uncertainties, including loss of investor confidence and negative impacts on the Company’s common share price; and other risks and uncertainties described in more detail in Eupraxia’s public filings on SEDAR+ (sedarplus.ca) and EDGAR (sec.gov). Although Eupraxia has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements and information, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement or information can be guaranteed. Except as required by applicable securities laws, forward-looking statements and information speak only as of the date on which they are made and Eupraxia undertakes no obligation to publicly update or revise any forward-looking statement or information, whether as a result of new information, future events or otherwise.   

For investor and media inquiries, please contact: 

James Meikle, Eupraxia Pharmaceuticals Inc. 
236-330-7084 
[email protected] 

or 

Kevin Gardner, on behalf of: 
Eupraxia Pharmaceuticals Inc. 
617-283-2856 
[email protected] 

SOURCE Eupraxia Pharmaceuticals Inc. 



Mobilicom Secures $2.2 Million in New Purchase Orders for U.S. DoW Program of Record with Tier-1 Drone Manufacturer

Ongoing production scale orders from U.S. Tier-1 customer accelerate as drones are delivered under a $249 million Program of Record   

Deliveries have already commenced and are expected to conclude well within 2026



Palo Alto, California, April 21, 2026 (GLOBE NEWSWIRE) — Mobilicom Limited (Nasdaq: MOB, MOBBW) (“Mobilicom” or the “Company”), a provider of cybersecurity and robust solutions for drones and robotics, today announced that it has received new purchase orders valued at $2.2 million from a large manufacturer of small-sized drones in the U.S. This large defense manufacturer customer, with over $5 billion in annual sales, integrated Mobilicom’s SkyHopper PRO and ICE Electronic Warfare Resistance & Cybersecurity Suite as essential systems into its loitering munitions drones sold to the U.S. Department of War (DoW) under a Program of Record valued at $249 million. Shipments against the recent purchase orders have commenced and will continue into 2026 with full delivery expected before the end of the year.

This latest $2.2 million order marks a significant increase in the Company’s engagement with this customer, building on a prior $1.5 million order and a series of initial orders of approximately $200,000 each — all under a single program. The trajectory underscores the expanding adoption and growing operational reliance on Mobilicom’s solutions.

“The Program of Record win by our Tier-1 customer marks a major inflection point for Mobilicom as we receive increasingly larger sized orders at an accelerating pace,” stated the Founder and CEO of Mobilicom, Oren Elkayam. “As our embedded SkyHopper PRO datalinks and ICE Cybersecurity are the backbone powering these mission-critical drones, we are well positioned to benefit from further accelerating production and rising order volumes over the coming years. With secured, multi-year Program of Record funding and growing global demand for loitering munitions, this milestone strengthens our incumbency advantage and reinforces our role in supporting long-term U.S. and allied defense programs.”

About Mobilicom

Mobilicom is a leading provider of cybersecure robust solutions for the rapidly growing defense and commercial drones and robotics market. Mobilicom’s large portfolio of field-proven technologies includes cybersecurity, software, hardware, and professional services that power, connect, guide, and secure drones and robotics. Through deployments across the globe with over 50 customers, including the world’s largest drone manufacturers, Mobilicom’s end-to-end solutions are used in mission-critical functions.

For investors, please use https://ir.mobilicom.com/  
For company, please use www.mobilicom.com

Forward Looking Statements

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. For example, the Company is using forward-looking statements when it discusses that it is well positioned to benefit from further accelerating production and rising order volumes over the coming years. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Mobilicom Limited’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the Company’s filings with the Securities and Exchange Commission.

Forward-looking statements contained in this announcement are made as of this date, and Mobilicom Limited undertakes no duty to update such information except as required under applicable law.

For more information on Mobilicom, please contact:

Liad Gelfer

Mobilicom Ltd
[email protected]



Valmont Reports First Quarter 2026 Results and Raises Full-Year 2026 EPS Guidance

Valmont Reports First Quarter 2026 Results and Raises Full-Year 2026 EPS Guidance

OMAHA, Neb.–(BUSINESS WIRE)–
Valmont® Industries, Inc. (NYSE: VMI), a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity, today reported financial results for the first quarter ended March 28, 2026.

President and Chief Executive Officer Avner M. Applbaum commented, “We delivered a strong start to 2026, including record first-quarter earnings per share, reflecting solid sales growth and margin expansion driven primarily by pricing strength and higher volumes in North America Utility. This performance reflects the team’s focus on value-based pricing, a disciplined commercial approach, and continued progress on our capacity and throughput initiatives. We are advancing our strategy and key value drivers to support sustainable growth and long-term shareholder value.

“In Infrastructure, demand in North America Utility remains underpinned by long-term investment trends, including rising energy demand, grid modernization, and electrification. As we move through the year, growth is supported by our capacity investments and strong operational and commercial execution.

“In Agriculture, we are managing through a more cautious near-term market environment, with an emphasis on profitability. We continue to position the business for future growth through investment in aftermarket parts and technology solutions that improve water efficiency and enhance grower productivity.”

FirstQuarter 2026 Highlights (all metrics compared to First Quarter 2025 unless otherwise noted)

  • Net sales increased 6.2% to $1.03 billion

  • Operating income increased 21.3% to $155.6 million or 15.1% of net sales, compared to $128.3 million or 13.2% of net sales

  • Diluted earnings per share increased 27.5% to $5.51, compared to $4.32

  • Realigned the product line reporting1 within the segments to better reflect the markets served and how they are managed

  • Cash and cash equivalents were $160.2 million and net leverage ratio2 was ~1.1x

  • Returned $70.8 million to shareholders through $57.5 million in share repurchases and $13.3 million in dividends; increased the quarterly cash dividend by 13% to $0.77 per share ($3.08 annualized)

  • Invested $34.6 million in capital expenditures to primarily support capacity investments for the North America Utility product line

1Prior-period amounts have been recast to conform to the current-period presentation. 

2Please see Reg G reconciliation to GAAP measures at end of document

 
 

Key Financial Metrics

 
 

First Quarter 2026

 

 

 

(In thousands, except per-share amounts)

 

3/28/2026

 

3/29/2025

 

 

 

 

 

Q1 2026

 

Q1 2025

 

vs. Q1 2025

 

Net Sales

 

$

1,029,197

 

$

969,314

 

6.2%

 

Gross Profit

 

 

316,878

 

 

291,102

 

8.9%

 

Gross Profit as a % of Net Sales

 

 

30.8%

 

 

30.0%

 

 

 

Operating Income

 

 

155,626

 

 

128,314

 

21.3%

 

Operating Income as a % of Net Sales

 

 

15.1%

 

 

13.2%

 

 

 

Net Earnings Attributable to Valmont Industries, Inc.

 

 

108,033

 

 

87,261

 

23.8%

 

Diluted Earnings per Share

 

 

5.51

 

 

4.32

 

27.5%

 

Weighted Average Shares Outstanding

 

 

19,616

 

 

20,196

 

 

 

First Quarter 2026 Segment Review (all metrics compared to First Quarter 2025 unless otherwise noted)

Infrastructure(78.0% of Net Sales)

Products and solutions to serve the infrastructure markets of utility, lighting, transportation, and telecommunications, along with coatings services to protect metal products

Sales increased 14.1% to $805.9 million, compared to $706.2 million.

Infrastructure end markets remain strong supporting 27.4% growth in North America Utility and a 13.3% increase in North America Coatings sales driven by favorable pricing and higher volumes. International sales increased due to favorable foreign exchange. These increases were partially offset by lower volumes in North America Lighting and Transportation and North America Telecommunications.

Operating income increased 22.0% to $143.0 million or 17.8% of net sales, compared to $117.2 million or 16.7% of net sales. The improvement was primarily attributable to higher pricing and volumes, and an improved global cost structure.

Agriculture (22.0% of Net Sales)

Center pivot and linear irrigation equipment components for agricultural markets, including aftermarket parts and tubular products, and advanced technology solutions for precision agriculture

Sales decreased 15.1% to $227.0 million, compared to $267.3 million.

In North America, irrigation sales increased 1.5% due to favorable pricing, partially offset by lower volumes amid continued agriculture market softness. International sales decreased 32.7% driven primarily by operational disruptions due to the ongoing Middle East conflict and lower volumes in Brazil.

Operating income decreased 7.5% to $33.5 million or 14.8% of net sales, compared to $36.2 million or 13.6% of net sales. The decrease was driven primarily by lower volumes partially offset by positive pricing and reduced SG&A.

Full-Year 2026 Financial Outlook and Key Assumptions

The Company is raising its full-year 2026 diluted EPS outlook and updating its key assumptions.

Metric

Previous Outlook

Updated Outlook

Net Sales

$4.2 to $4.4 billion

No change

Infrastructure Net Sales

$3.25 to $3.4 billion

$3.3 to $3.45 billion

Agriculture Net Sales

$0.95 to $1.0 billion

$0.9 to $0.95 billion

Diluted Earnings per Share

$20.50 to $23.50

$21.50 to $23.50

Capital Expenditures

$170 to $200 million

No change

Effective Tax Rate

~26.0%

No change

Key Assumptions

  • Steel cost assumptions are aligned with futures markets as of April 17, 2026

  • Foreign currency assumptions based on FX rates as of April 17, 2026

  • This outlook includes the current tariffs as of April 17, 2026 and assumes no material change to the current trade or tariff environment

A live audio discussion with Avner M. Applbaum, President and Chief Executive Officer, and John Schwietz, Executive Vice President and Chief Financial Officer, will take place on Tuesday, April 21, 2026 at 8:00 a.m. CT. The discussion can be accessed by telephone at +1 877.407.6184 or +1 201.389.0877 (no Conference ID needed) or via webcast at the following link: Valmont Industries 1Q 2026 Earnings Conference Call. A slide presentation will be available for download on the Investors page of valmont.com during the webcast. A replay of the event will be accessible three hours after the call at the above link or by telephone at +1 877.660.6853 or +1 201.612.7415 using access code 13756344. The replay will be available until 10:59 p.m. CT on Tuesday, April 28, 2026.

About Valmont Industries, Inc.

For more than 80 years, Valmont has been a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity. We are committed to customer-focused innovation that delivers lasting value. Learn more about how we’re Conserving Resources. Improving Life.® at valmont.com.

Concerning Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on assumptions made by management, considering its experience in the industries where Valmont operates, perceptions of historical trends, current conditions, expected future developments, and other relevant factors. It is important to note that these statements are not guarantees of future performance or results. They involve risks, uncertainties (some of which are beyond Valmont’s control), and assumptions. While management believes these forward-looking statements are based on reasonable assumptions, numerous factors could cause actual results to differ materially from those anticipated. These factors include, among other things, risks described in Valmont’s reports to the Securities and Exchange Commission (“SEC”), the Company’s actual cash flows and net income, future economic and market circumstances, industry conditions, company performance and financial results, operational efficiencies, availability and price of raw materials, availability and market acceptance of new products, product pricing, domestic and international competitive environments, geopolitical risks, and actions and policy changes by domestic and foreign governments, including tariffs. The Company cautions that any forward-looking statements in this release are made as of its publication date and does not undertake to update these statements, except as required by law.

The Company may provide certain non-GAAP financial measures (adjusted diluted earnings per share and adjusted effective tax rate) on a forward-looking basis from time to time. These measures are typically calculated by excluding the impact of items such as foreign exchange, acquisitions, divestitures, realignment or restructuring expenses, goodwill or intangible asset impairment, changes in tax laws or rates, change in redemption value of redeemable noncontrolling interests, and other non-recurring items. To the extent the Company provide forward-looking non-GAAP financial measures, reconciliations to the most directly comparable GAAP financial measures are not provided, as the Company cannot do so without unreasonable effort due to the inherent uncertainty and difficulty in predicting the timing and financial impact of such items. For the same reasons, the Company cannot assess the likely significance of unavailable information, which could be material to future results.

Website and Social Media Disclosure

The Company uses its website and social media channels, as identified on its website, to distribute company information. Posts on these channels may contain material information. Therefore, investors should monitor these channels alongside the Company’s press releases, SEC filings, and public conference calls and webcasts. The contents of the Company’s website and social media channels are not considered part of this press release.

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS

(Dollars and shares in thousands, except per-share amounts)

(Unaudited)

 

 

 

 

 

 

 

 

 

Thirteen weeks ended

 

 

March 28,

 

March 29,

 

 

2026

 

2025

Net sales

 

$

1,029,197

 

 

$

969,314

 

Cost of sales

 

 

712,319

 

 

 

678,212

 

Gross profit

 

 

316,878

 

 

 

291,102

 

Selling, general, and administrative expenses

 

 

161,252

 

 

 

162,788

 

Operating income

 

 

155,626

 

 

 

128,314

 

Other income (expenses):

 

 

 

 

 

 

Interest expense

 

 

(9,411

)

 

 

(10,115

)

Interest income

 

 

1,377

 

 

 

3,394

 

Loss on deferred compensation investments

 

 

(1,558

)

 

 

(841

)

Other

 

 

(895

)

 

 

(2,730

)

Total other expenses

 

 

(10,487

)

 

 

(10,292

)

Earnings before income taxes and equity method investment loss

 

 

145,139

 

 

 

118,022

 

Income tax expense

 

 

37,115

 

 

 

30,799

 

Equity method investment loss

 

 

 

 

 

(560

)

Net earnings

 

 

108,024

 

 

 

86,663

 

Loss attributable to redeemable noncontrolling interests

 

 

9

 

 

 

598

 

Net earnings attributable to Valmont Industries, Inc.

 

$

108,033

 

 

$

87,261

 

 

 

 

 

 

 

 

Weighted average shares outstanding – Basic

 

 

19,475

 

 

 

20,047

 

Earnings per share – Basic

 

$

5.55

 

 

$

4.35

 

 

 

 

 

 

 

 

Weighted average shares outstanding – Diluted

 

 

19,616

 

 

 

20,196

 

Earnings per share – Diluted

 

$

5.51

 

 

$

4.32

 

 

 

 

 

 

 

 

Cash dividends per share

 

$

0.77

 

 

$

0.68

 

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

SUMMARY OPERATING RESULTS

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

Thirteen weeks ended

 

 

March 28,

 

March 29,

 

 

2026

 

2025

Infrastructure

 

 

 

 

 

 

Net sales

 

$

803,180

 

 

$

703,491

 

Gross profit

 

 

244,190

 

 

 

212,875

 

as a percentage of net sales

 

 

30.4

%

 

 

30.3

%

Selling, general, and administrative expenses

 

 

101,167

 

 

 

95,663

 

as a percentage of net sales

 

 

12.6

%

 

 

13.6

%

Operating income

 

 

143,023

 

 

 

117,212

 

as a percentage of net sales

 

 

17.8

%

 

 

16.7

%

 

 

 

 

 

 

 

Agriculture

 

 

 

 

 

 

Net sales

 

$

226,017

 

 

$

265,823

 

Gross profit

 

 

72,688

 

 

 

78,227

 

as a percentage of net sales

 

 

32.2

%

 

 

29.4

%

Selling, general, and administrative expenses

 

 

39,185

 

 

 

41,990

 

as a percentage of net sales

 

 

17.3

%

 

 

15.8

%

Operating income

 

 

33,503

 

 

 

36,237

 

as a percentage of net sales

 

 

14.8

%

 

 

13.6

%

 

 

 

 

 

 

 

Corporate

 

 

 

 

 

 

Selling, general, and administrative expenses

 

$

20,900

 

 

$

25,135

 

Operating loss

 

 

(20,900

)

 

 

(25,135

)

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

SUMMARY OPERATING RESULTS

(Dollars in thousands)

(Unaudited)

 

In the first quarter of fiscal 2026, the Company revised its product line presentation to better reflect how the business is currently managed. Within the Infrastructure segment, product lines are now presented as North America Utility, North America Lighting and Transportation, North America Coatings, North America Telecommunications, and International Infrastructure and Solar, replacing the previous presentation of Utility, Lighting and Transportation, Coatings, Telecommunications, and Solar. Within the Agriculture segment, product lines are now presented as Agriculture, replacing the previous presentation of Irrigation Equipment and Parts and Technology Products and Services. The prior period product line amounts have been recast to conform to the current period presentation.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Thirteen weeks ended March 28, 2026

 

    

Infrastructure

    

Agriculture

 

Intersegment

    

Consolidated

Geographical Market:

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

$

 667,528

 

$

 139,593

 

$

 (3,720

)

 

$

 803,401

International

 

 

 138,393

 

 

 87,403

 

 

 —

 

 

 

 225,796

Total sales

 

$

 805,921

 

$

 226,996

 

$

 (3,720

)

 

$

 1,029,197

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Line:

 

 

  

 

 

  

 

 

  

 

 

  

North America Utility

 

$

 424,184

 

$

 —

 

$

 —

 

 

$

 424,184

North America Lighting and Transportation

 

 

 118,652

 

 

 —

 

 

 —

 

 

 

 118,652

North America Coatings

 

 

 63,134

 

 

 —

 

 

 (2,741

)

 

 

 60,393

North America Telecommunications

 

 

 61,504

 

 

 —

 

 

 —

 

 

 

 61,504

International Infrastructure and Solar

 

 

 138,447

 

 

 —

 

 

 —

 

 

 

 138,447

Agriculture

 

 

 —

 

 

 226,996

 

 

 (979

)

 

 

 226,017

Total sales

 

$

 805,921

 

$

 226,996

 

$

 (3,720

)

 

$

 1,029,197

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Thirteen weeks ended March 29, 2025

 

    

Infrastructure

    

Agriculture

 

Intersegment

    

Consolidated

Geographical Market:

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

$

 577,197

 

$

 137,476

 

$

 (4,112

)

 

$

 710,561

International

 

 

 129,024

 

 

 129,795

 

 

 (66

)

 

 

 258,753

Total sales

 

$

 706,221

 

$

 267,271

 

$

 (4,178

)

 

$

 969,314

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Line:

 

 

 

 

 

 

 

 

 

 

 

 

North America Utility

 

$

 332,836

 

$

 —

 

$

 —

 

 

$

 332,836

North America Lighting and Transportation

 

 

 124,123

 

 

 —

 

 

 —

 

 

 

 124,123

North America Coatings

 

 

 55,708

 

 

 —

 

 

 (2,664

)

 

 

 53,044

North America Telecommunications

 

 

 63,988

 

 

 —

 

 

 —

 

 

 

 63,988

International Infrastructure and Solar

 

 

 129,566

 

 

 —

 

 

 (66

)

 

 

 129,500

Agriculture

 

 

 —

 

 

 267,271

 

 

 (1,448

)

 

 

 265,823

Total sales

 

$

 706,221

 

$

 267,271

 

$

 (4,178

)

 

$

 969,314

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

March 28,

 

December 27,

 

 

2026

 

2025

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

160,189

 

$

187,140

Receivables, net

 

 

652,749

 

 

590,127

Inventories

 

 

587,715

 

 

566,396

Contract assets

 

 

250,411

 

 

266,922

Prepaid expenses and other current assets

 

 

120,931

 

 

109,063

Total current assets

 

 

1,771,995

 

 

1,719,648

Property, plant, and equipment, net

 

 

685,952

 

 

673,863

Goodwill and other non-current assets

 

 

977,218

 

 

975,818

Total assets

 

$

3,435,165

 

$

3,369,329

 

 

 

 

 

 

 

LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Current installments of long-term debt

 

$

 

$

513

Mandatorily redeemable financial instrument

 

 

 

 

8,922

Accounts payable

 

 

374,208

 

 

359,539

Accrued expenses

 

 

266,309

 

 

284,751

Contract liabilities

 

 

77,112

 

 

52,013

Income taxes payable

 

 

13,283

 

 

12,604

Dividends payable

 

 

14,948

 

 

13,278

Total current liabilities

 

 

745,860

 

 

731,620

Long-term debt, excluding current installments

 

 

790,292

 

 

795,150

Operating lease liabilities

 

 

131,008

 

 

130,007

Other non-current liabilities

 

 

79,422

 

 

70,267

Total liabilities

 

 

1,746,582

 

 

1,727,044

Redeemable noncontrolling interests

 

 

9,301

 

 

9,498

Shareholders’ equity

 

 

1,679,282

 

 

1,632,787

Total liabilities, redeemable noncontrolling interests, and shareholders’ equity

 

$

3,435,165

 

$

3,369,329

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

Thirteen weeks ended

 

 

March 28,

 

March 29,

 

 

2026

 

2025

Cash flows from operating activities:

 

 

 

 

 

 

Net earnings

 

$

108,024

 

 

$

86,663

 

Depreciation and amortization

 

 

22,607

 

 

 

21,518

 

Contribution to defined benefit pension plan

 

 

(886

)

 

 

(1,492

)

Changes in assets and liabilities

 

 

(48,541

)

 

 

(60,045

)

Other, net

 

 

22,269

 

 

 

18,486

 

Net cash flows from operating activities

 

 

103,473

 

 

 

65,130

 

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property, plant, and equipment

 

 

(34,568

)

 

 

(30,319

)

Acquisitions, net of cash acquired

 

 

(11,195

)

 

 

 

Other, net

 

 

2,462

 

 

 

128

 

Net cash flows from investing activities

 

 

(43,301

)

 

 

(30,191

)

Cash flows from financing activities:

 

 

 

 

 

 

Net repayments on short-term borrowings

 

 

 

 

 

(1,601

)

Proceeds from long-term borrowings

 

 

50,000

 

 

 

60,000

 

Principal repayments on long-term borrowings

 

 

(55,555

)

 

 

(60,174

)

Dividends paid

 

 

(13,279

)

 

 

(12,019

)

Purchases of redeemable noncontrolling interests

 

 

(8,922

)

 

 

 

Repurchases of common stock

 

 

(57,550

)

 

 

 

Other, net

 

 

(1,919

)

 

 

(3,199

)

Net cash flows from financing activities

 

 

(87,225

)

 

 

(16,993

)

Effect of exchange rates on cash and cash equivalents

 

 

102

 

 

 

2,138

 

Net change in cash and cash equivalents

 

 

(26,951

)

 

 

20,084

 

Cash and cash equivalents—beginning of period

 

 

187,140

 

 

 

164,315

 

Cash and cash equivalents—end of period

 

$

160,189

 

 

$

184,399

 

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

USE OF NON-GAAP FINANCIAL MEASURES

Management utilizes non-GAAP financial measures to assess the Company’s historical and prospective financial performance, evaluate operational profitability on a consistent basis, factor into executive compensation decisions, and enhance transparency for the investment community. These non-GAAP measures are intended to supplement, not replace, the Company’s reported financial results prepared in accordance with GAAP. It is important to note that other companies may calculate these measures differently, which can limit their usefulness for comparison across organizations.

The following non-GAAP measures may be included in financial releases and other financial communications:

  • Adjusted Gross Profit, Adjusted Gross Margin, Adjusted Operating Income, Adjusted Operating Margin, Adjusted Net Earnings, Adjusted Diluted EPS, and Adjusted Effective Tax Rate: These metrics provide meaningful supplemental insights into the Company’s operating performance by excluding items that are not considered part of core operating results. This approach enhances comparability across reporting periods. Adjustments may include costs or benefits associated with acquisitions, divestitures, expenses related to realignment or restructuring programs, goodwill or intangible asset impairment, significant expenses or benefits from changes in tax laws or rates, cumulative effects of changes in accounting standards, refinancing-related expenses, a loss or a gain from a partial or full settlement of the U.K. defined benefit pension plan obligation, losses from natural disasters, change in redemption value of redeemable noncontrolling interests, and other non-recurring items.
  • Adjusted EBITDA: This metric is a key component of a financial ratio included in the covenants of our major debt agreements. It is calculated as net earnings before interest, taxes, depreciation, amortization, stock-based compensation, and other adjustments as outlined in the applicable debt agreements. This metric offers investors and analysts valuable insights into the Company’s core operating performance. Adjusted EBITDA margin is also used to evaluate profitability.
  • Leverage Ratio: This ratio is calculated by taking the sum of interest-bearing debt, minus unrestricted cash in excess of $50.0 million (but not exceeding $500.0 million), and dividing it by Adjusted EBITDA. This is a key financial ratio included in the covenants of our major debt agreements and is calculated on a rolling four-fiscal-quarter basis.
  • Free Cash Flow: Calculated as net cash provided by operating activities minus capital expenditures, free cash flow serves as an indicator of the Company’s financial strength. However, this measure does not fully reflect the Company’s ability to deploy cash freely, as it has obligations such as debt repayments and other fixed commitments.
  • Backlog: This operating measure is used to evaluate future potential sales revenue. An order is included in the backlog upon receipt of a customer purchase order or the execution of a sales order contract. Backlog is particularly relevant to the Infrastructure segment due to the longer-term nature of its projects. However, backlog is not a term defined under U.S. GAAP and does not measure contract profitability. It should not be viewed as the sole indicator of future revenue, as many projects with short lead times book-and-bill within the same reporting period and are not included in the backlog.
  • ROIC: Return on invested capital (“ROIC”) and adjusted ROIC are key operating ratios that enable investors to assess our operating performance relative to the investment needed to generate operating profit. ROIC is calculated as after-tax operating income divided by the average of beginning and ending invested capital. Adjusted ROIC is calculated as after-tax adjusted operating income divided by the average of beginning and ending invested capital. Invested capital represents total assets minus total liabilities (excluding interest-bearing debt and redeemable noncontrolling interests).

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

REGULATION G RECONCILIATION OF ADJUSTED EBITDA

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

Four fiscal quarters ended

 

 

March 28,

 

 

2026

Net cash flows from operating activities

 

$

494,827

 

Interest expense

 

 

39,838

 

Income tax expense

 

 

30,180

 

Impairment of long-lived assets

 

 

(91,337

)

Deferred income taxes

 

 

13,968

 

Redeemable noncontrolling interests

 

 

(4,004

)

Net periodic pension cost

 

 

(1,873

)

Contribution to defined benefit pension plan

 

 

2,553

 

Changes in assets and liabilities

 

 

70,920

 

Other

 

 

(1,782

)

Impairment of long-lived assets

 

 

91,337

 

Realignment charges

 

 

16,066

 

Non-recurring non-cash charges1

 

 

3,918

 

Proforma acquisition adjustment

 

 

6,424

 

Adjusted EBITDA

 

$

671,035

 

 

 

 

 

Net earnings attributable to Valmont Industries, Inc.

 

$

371,045

 

Interest expense

 

 

39,838

 

Income tax expense

 

 

30,180

 

Depreciation and amortization

 

 

89,598

 

Stock-based compensation

 

 

22,629

 

Impairment of long-lived assets

 

 

91,337

 

Realignment charges

 

 

16,066

 

Non-recurring non-cash charges1

 

 

3,918

 

Proforma acquisition adjustment

 

 

6,424

 

Adjusted EBITDA

 

$

671,035

 

 

1 Non-recurring non-cash charges consist of asset valuation adjustments for a joint venture ag solar business.

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

REGULATION G RECONCILIATION OF LEVERAGE RATIO

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

March 28,

 

 

2026

Interest-bearing debt, excluding origination fees and discounts of $24,708

 

$

815,000

Less: Cash and cash equivalents in excess of $50,000

 

 

110,189

Net indebtedness

 

$

704,811

Adjusted EBITDA

 

 

671,035

Leverage ratio

 

 

1.05

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

BACKLOG

(Dollars in millions)

(Unaudited)

 

 

 

 

 

 

 

 

 

March 28,

 

December 27,

 

 

2026

 

2025

Infrastructure

 

$

1,551.5

 

$

1,548.3

Agriculture

 

 

102.8

 

 

105.4

Total backlog

 

$

1,654.3

 

$

1,653.7

 

Renee Campbell

[email protected]

KEYWORDS: Nebraska United States North America

INDUSTRY KEYWORDS: Other Manufacturing Technology Agritech Manufacturing Other Natural Resources Machinery Machine Tools, Metalworking & Metallurgy Agriculture Natural Resources

MEDIA:

Logo
Logo

NIQ and Stirista Announce Collaboration to Advance Privacy-Safe Audience Solutions

NIQ and Stirista Announce Collaboration to Advance Privacy-Safe Audience Solutions

Relationship aligns purchase-based intelligence with data-driven activation capabilities to support more effective advertising planning and activation

CHICAGO–(BUSINESS WIRE)–
NIQ (NYSE: NIQ), a leading consumer intelligence company, and Stirista, a provider of identity-driven marketing solutions, today announced a strategic collaboration to develop new audience solutions, media planning capabilities, and activation use cases for advertisers and brands.

Through the relationship, NIQ and Stirista will enhance their abilities to develop robust audience definitions, improve campaign planning, and support marketing performance across channels. The collaboration also enables marketers to harness modeled intent data and purchase-based insights to activate campaigns through Stirista’s platform.

As part of the relationship, NIQ will use insights informed by the collaboration with Stirista to advance its consumer research and analytics, strengthening how it supports audience design and planning. Specifically, Stirista will contribute privacy-safe consumer insights related to mobile device usage, professional status, and digital media consumption. Informed by these insights, NIQ will enhance its audience design and segmentation capabilities within its privacy-safe consumer framework.

“Today’s advertisers need to move seamlessly from insight to action without compromising privacy,” said Josh Pisano, General Manager of Global Media, NIQ. “By combining NIQ’s intelligence with Stirista’s activation platform, we’re enabling brands to plan smarter and activate with greater confidence across the media ecosystem.”

NIQ will provide Stirista with aggregated, omni-channel shopper insights. That intelligence strengthens Stirista’s identity-based insights and informs activation workflows within Stirista’s platform, allowing marketers to reach audiences across CTV, email, and digital without needing to rebuild them across systems.

“By leveraging NIQ’s purchase-based insights, Stirista can better design audiences and activate them through its platform and partners, particularly for CPG brands,” said Ajay Gupta, Stirista CEO and Founder. “These audiences are informed by consumer purchase insights that complement our modeled intent signals, enabling more effective targeting across programmatic media and targeted email campaigns.”

About NIQ

NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete and trusted understanding of consumer buying behavior and revealing new pathways to growth. By combining an unmatched global data footprint and granular consumer and retail measurement with decades of AI modeling expertise, NIQ builds decision systems that help companies turn complex data into confident action.

With operations in more than 90 countries, NIQ covers approximately 82% of the world’s population and more than $7.4 trillion in global consumer spend. Through cloud-based platforms, advanced analytics and AI-driven insights, NIQ delivers The Full View™—helping brands and retailers understand what consumers buy, why they buy it, and what to do next.

For more information, please visit www.niq.com.

© 2026 Nielsen Consumer LLC. All Rights Reserved.

About Stirista

Stirista is a data-driven marketing technology provider that combines the power of authoritative identity data with the execution of omnichannel marketing. Through its data and customer-centric approach, Stirista helps brands increase loyalty and acquire new customers across digital, email, CTV, and social channels. For more information, visit www.stirista.com.

Media Contact:

NIQ North America

[email protected]

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Software Other Retail Professional Services Consumer Technology Artificial Intelligence Data Analytics Online Privacy Retail Other Consumer Marketing Advertising Communications

MEDIA:

Logo
Logo

Littelfuse Appoints Anne-Marie D’Angelo as Chief Legal Officer and Corporate Secretary

Littelfuse Appoints Anne-Marie D’Angelo as Chief Legal Officer and Corporate Secretary

CHICAGO–(BUSINESS WIRE)–Littelfuse, Inc. (NASDAQ: LFUS), a leader in developing smart solutions that enable safe and efficient electrical energy transfer, today announced that Anne‑Marie D’Angelo will join the company as Chief Legal Officer and Corporate Secretary, effective May 1, 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421867892/en/

Anne-Marie D’Angelo, Littelfuse Chief Legal Officer and Corporate Secretary

Anne-Marie D’Angelo, Littelfuse Chief Legal Officer and Corporate Secretary

Greg Henderson, President and Chief Executive Officer, commented, “We are pleased to welcome Anne‑Marie to the Littelfuse executive leadership team. She is a proven leader with an exceptional track record of navigating complex global legal and regulatory landscapes. Her deep expertise in corporate governance, M&A, and strategic planning will be invaluable as we continue to drive growth and deliver long-term value for our shareholders.”

Ms. D’Angelo brings over two decades of legal and executive experience across diverse, highly regulated industries. Most recently, she served as Executive Vice President and General Counsel at Hilton Worldwide Holdings, Inc., where she led a global team of legal and compliance professionals and served as a trusted advisor to the Board of Directors.

Prior to Hilton, Ms. D’Angelo held senior leadership roles including Chief Legal and Government Affairs Officer at Molson Coors Beverage Company and Executive Vice President and General Counsel at NiSource. She also served as General Counsel and Corporate Secretary for Global Brass and Copper Holdings, Inc., and spent over a decade in various legal leadership positions at McDonald’s Corporation.

D’Angelo holds a Juris Doctor from the University of Notre Dame Law School and a Bachelor of Arts from the College of the Holy Cross.

About Littelfuse

Littelfuse, Inc. (NASDAQ: LFUS) is a diversified, industrial technology manufacturing company empowering a sustainable, connected, and safer world. Across more than 20 countries, and with approximately 17,000 global associates, we partner with customers to design and deliver innovative, reliable solutions. Serving over 100,000 end customers, our products are found in a variety of industrial, transportation, and electronics end markets–everywhere, every day. Learn more at Littelfuse.com.

LFUS-F

David Kelley

224-727-2535

[email protected]

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Hardware Manufacturing Other Manufacturing Electronic Design Automation Technology

MEDIA:

Photo
Photo
Anne-Marie D’Angelo, Littelfuse Chief Legal Officer and Corporate Secretary
Logo
Logo

Mueller Industries, Inc. Reports First Quarter 2026 Earnings

Mueller Industries, Inc. Reports First Quarter 2026 Earnings

COLLIERVILLE, Tenn.–(BUSINESS WIRE)–
Mueller Industries, Inc. (NYSE: MLI) announces results for the first quarter of 2026. Comparisons are to the first quarter of 2025.

  • Net Sales increased to $1.19 billion versus $1.00 billion.

  • Net Income increased to $239.0 million versus $157.4 million.

  • Operating Income increased to $312.2 million versus $206.3 million.

  • Diluted EPS increased to $2.16 versus $1.39.

  • Dividends per share increased to $.35 versus $.25.

First Quarter Financial and Operating Highlights:

  • COMEX copper averaged $5.80 per pound during the quarter, a 26.8 percent increase.

  • Improved sales in our industrial, electrical, commercial and mechanical markets, combined with higher selling prices stemming from the rise in raw material costs, contributed to the overall increase in net sales.

  • Our reported operating income includes a gain of $41.4 million on the sale of our Sherwood Valve business. The prior year period included a gain of $14.5 million on the sale of assets. Adjusting for these gains, our operating income increased 41 percent.

  • Net cash generated from operations was $79.7 million. We utilized $75.0 million during the quarter to repurchase 650,000 shares of our common stock.

  • Our cash balance at quarter end was $1.38 billion, with no debt, and our current ratio remains strong at 5.4 to 1.

Regarding the results, Greg Christopher, Mueller’s CEO said, “Solid operational execution, including effective raw material and price management and prudent cost controls, along with our diverse end market portfolio, all contributed to the best first quarter earnings in our Company’s history. In addition, our continued strong cash generation supported components of our overall capital allocation strategy, including the stock buyback and a 40 percent increase in our quarterly dividend, our sixth consecutive annual double-digit increase.

We also were excited to complete the acquisition of Bison Metals Technologies on March 30th, and to welcome Bison’s experienced and talented leadership team. The acquisition will immediately provide important synergies that will benefit our entire North American copper tube products platform and enable us to increase our collective copper tube manufacturing capacities. Out of the gate, the integration has been seamless and successful.”

Regarding the outlook he added, “Business conditions and our outlook remain consistent with those described in our recently published annual report. Shifts in patterns of construction and market effects from tariffs have strengthened demand for higher margin products, and as we adjust to the changes in mix, we expect our production and shipments to further improve. We also look forward to an improvement in economic conditions abroad, and particularly, an improvement in the residential and commercial construction markets in the U.S. Once those markets recover, we are exceedingly well positioned to benefit.”

Mueller Industries, Inc. (NYSE: MLI) is an industrial corporation whose holdings manufacture vital goods for important markets such as air, water, oil and gas distribution; climate comfort; food preservation; electrical transmission; medical; aerospace; and automotive. It includes a network of companies and brands throughout North America, Europe, Asia, and the Middle East.

Statements in this release that are not strictly historical may be “forward-looking” statements, which involve risks and uncertainties. These include economic and currency conditions, continued availability of raw materials and energy, market demand, pricing, competitive and technological factors, and the availability of financing, among others, as set forth in the Company’s SEC filings. The words “outlook,” “estimate,” “project,” “intend,” “expect,” “believe,” “target,” “encourage,” “anticipate,” “appear,” and similar expressions are intended to identify forward-looking statements. The reader should not place undue reliance on forward-looking statements, which speak only as of the date of this report. The Company has no obligation to publicly update or revise any forward-looking statements to reflect events after the date of this report.

MUELLER INDUSTRIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

 

 

 

For the Quarter Ended

(In thousands, except per share data)

 

March 28,

2026

 

March 29,

2025

 

 

 

 

 

Net sales

 

$

1,193,005

 

 

$

1,000,165

 

 

 

 

 

 

Cost of goods sold

 

 

834,561

 

 

 

728,185

 

Depreciation and amortization

 

 

16,652

 

 

 

17,123

 

Selling, general, and administrative expense

 

 

66,785

 

 

 

63,060

 

Loss (gain) on disposal of assets, net

 

 

1,533

 

 

 

(14,465

)

Gain on sale of business

 

 

(41,407

)

 

 

 

Asset impairments

 

 

2,653

 

 

 

 

 

 

 

 

 

Operating income

 

 

312,228

 

 

 

206,262

 

 

 

 

 

 

Interest expense

 

 

 

 

 

(25

)

Interest income

 

 

11,870

 

 

 

9,901

 

Unrealized losses on short-term investments

 

 

(2,037

)

 

 

(5,010

)

Other (expense) income, net

 

 

(1,232

)

 

 

92

 

 

 

 

 

 

Income before income taxes

 

 

320,829

 

 

 

211,220

 

 

 

 

 

 

Income tax expense

 

 

(79,555

)

 

 

(51,475

)

Income (loss) from unconsolidated affiliates, net of foreign tax

 

 

115

 

 

 

(458

)

 

 

 

 

 

Consolidated net income

 

 

241,389

 

 

 

159,287

 

 

 

 

 

 

Net income attributable to noncontrolling interests

 

 

(2,371

)

 

 

(1,855

)

 

 

 

 

 

Net income attributable to Mueller Industries, Inc.

 

$

239,018

 

 

$

157,432

 

 

 

 

 

 

Weighted average shares for basic earnings per share

 

 

109,094

 

 

 

110,739

 

Effect of dilutive stock-based awards

 

 

1,815

 

 

 

2,333

 

 

 

 

 

 

Adjusted weighted average shares for diluted earnings per share

 

 

110,909

 

 

 

113,072

 

 

 

 

 

 

Basic earnings per share

 

$

2.19

 

 

$

1.42

 

 

 

 

 

 

Diluted earnings per share

 

$

2.16

 

 

$

1.39

 

 

 

 

 

 

Dividends per share

 

$

0.35

 

 

$

0.25

 

 

 

 

 

 

 

 

 

 

 

MUELLER INDUSTRIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME, CONTINUED

(Unaudited)

 

 

 

 

 

 

 

For the Quarter Ended

(In thousands)

 

March 28,

2026

 

March 29,

2025

 

 

 

 

 

Summary Segment Data:

 

 

 

 

 

 

 

 

 

Net sales:

 

 

 

 

Piping Systems Segment

 

$

760,528

 

 

$

639,683

 

Industrial Metals Segment

 

 

321,277

 

 

 

251,913

 

Climate Segment

 

 

123,765

 

 

 

123,107

 

Elimination of intersegment sales

 

 

(12,565

)

 

 

(14,538

)

 

 

 

 

 

Net sales

 

$

1,193,005

 

 

$

1,000,165

 

 

 

 

 

 

Operating income:

 

 

 

 

Piping Systems Segment

 

$

217,010

 

 

$

158,164

 

Industrial Metals Segment

 

 

44,271

 

 

 

30,084

 

Climate Segment

 

 

33,379

 

 

 

35,624

 

Unallocated income (expenses)

 

 

17,568

 

 

 

(17,610

)

 

 

 

 

 

Operating income

 

$

312,228

 

 

$

206,262

 

MUELLER INDUSTRIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

(Unaudited)

 

 

(In thousands)

 

March 28,

2026

 

December 27,

2025

ASSETS

 

 

 

 

Cash and cash equivalents

 

$

1,382,345

 

$

1,367,003

Short-term investments

 

 

20,696

 

 

22,733

Accounts receivable, net

 

 

670,511

 

 

475,566

Inventories

 

 

545,451

 

 

510,463

Other current assets

 

 

53,037

 

 

69,980

 

 

 

 

 

Total current assets

 

 

2,672,040

 

 

2,445,745

 

 

 

 

 

Property, plant, and equipment, net

 

 

530,300

 

 

536,466

Operating lease right-of-use assets

 

 

22,868

 

 

27,211

Other assets

 

 

717,155

 

 

723,607

 

 

 

 

 

Total assets

 

$

3,942,363

 

$

3,733,029

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

Accounts payable

 

$

243,539

 

$

180,577

Current portion of operating lease liabilities

 

 

7,907

 

 

8,520

Other current liabilities

 

 

247,835

 

 

224,037

 

 

 

 

 

Total current liabilities

 

 

499,281

 

 

413,134

 

 

 

 

 

Pension and postretirement liabilities

 

 

8,373

 

 

8,393

Environmental reserves

 

 

15,501

 

 

15,684

Deferred income taxes

 

 

32,499

 

 

31,640

Noncurrent operating lease liabilities

 

 

14,917

 

 

18,970

Other noncurrent liabilities

 

 

10,960

 

 

9,302

 

 

 

 

 

Total liabilities

 

 

581,531

 

 

497,123

 

 

 

 

 

Total Mueller Industries, Inc. stockholders’ equity

 

 

3,334,451

 

 

3,209,966

Noncontrolling interests

 

 

26,381

 

 

25,940

 

 

 

 

 

Total equity

 

 

3,360,832

 

 

3,235,906

 

 

 

 

 

Total liabilities and equity

 

$

3,942,363

 

$

3,733,029

MUELLER INDUSTRIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

For the Quarter Ended

(In thousands)

 

March 28,

2026

 

March 29,

2025

 

 

 

 

 

Cash flows from operating activities

 

 

 

 

Consolidated net income

 

$

241,389

 

 

$

159,287

 

Reconciliation of consolidated net income to net cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

 

16,652

 

 

 

17,123

 

Stock-based compensation expense

 

 

7,332

 

 

 

6,150

 

Provision for credit losses

 

 

861

 

 

 

99

 

(Income) loss from unconsolidated affiliates

 

 

(115

)

 

 

458

 

Dividends from unconsolidated affiliates

 

 

1,724

 

 

 

2,812

 

Loss (gain) on disposals of assets, net

 

 

1,533

 

 

 

(14,465

)

Gain on sale of business

 

 

(41,407

)

 

 

 

Unrealized losses on short-term investments

 

 

2,037

 

 

 

5,010

 

Impairment charges

 

 

2,653

 

 

 

 

Deferred income tax expense

 

 

2,036

 

 

 

1,651

 

Changes in assets and liabilities, net of effects of business sold:

 

 

 

 

Receivables

 

 

(200,192

)

 

 

(101,524

)

Inventories

 

 

(43,936

)

 

 

(18,542

)

Other assets

 

 

(612

)

 

 

410

 

Current liabilities

 

 

88,912

 

 

 

57,702

 

Other liabilities

 

 

1,509

 

 

 

(2,598

)

Other, net

 

 

(635

)

 

 

(14

)

 

 

 

 

 

Net cash provided by operating activities

 

$

79,741

 

 

$

113,559

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

Capital expenditures

 

$

(17,236

)

 

$

(16,592

)

Proceeds from sale of business, net of cash sold

 

 

57,004

 

 

 

 

Purchase of short-term investments

 

 

 

 

 

(26,633

)

Purchase of long-term investments

 

 

(834

)

 

 

(552

)

Proceeds from sales of assets

 

 

5

 

 

 

19,737

 

Other

 

 

 

 

 

600

 

 

 

 

 

 

Net cash provided by (used in) investing activities

 

$

38,939

 

 

$

(23,440

)

 

 

 

 

 

 

 

 

 

 

MUELLER INDUSTRIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

 

 

 

 

For the Quarter Ended

(In thousands)

 

March 28,

2026

 

March 29,

2025

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

Dividends paid to stockholders of Mueller Industries, Inc.

 

$

(38,043

)

 

$

(27,262

)

Repurchase of common stock

 

 

(74,981

)

 

 

(243,615

)

Repayments of debt

 

 

 

 

 

(56

)

Net cash used to settle stock-based awards

 

 

(535

)

 

 

(4,494

)

Dividends paid to noncontrolling interests

 

 

(4,766

)

 

 

(12,240

)

Other

 

 

3,100

 

 

 

 

 

 

 

 

 

Net cash used in financing activities

 

$

(115,225

)

 

$

(287,667

)

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

(1,810

)

 

 

392

 

 

 

 

 

 

Increase (decrease) in cash, cash equivalents, and restricted cash

 

 

1,645

 

 

 

(197,156

)

Cash, cash equivalents, and restricted cash at the beginning of the period

 

 

1,385,157

 

 

 

1,038,895

 

 

 

 

 

 

Cash, cash equivalents, and restricted cash at the end of the period

 

$

1,386,802

 

 

$

841,739

 

 

Jeffrey A. Martin

(901) 753-3226

KEYWORDS: Tennessee United States North America

INDUSTRY KEYWORDS: Chemicals/Plastics Oil/Gas Manufacturing Energy Other Manufacturing Steel

MEDIA:

Logo
Logo

Bowman to Attend May Investor Conferences

RESTON, Va., April 21, 2026 (GLOBE NEWSWIRE) — Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, announced it will participate in two investor conferences in May:

  • BofA Securities Industrials, Transportation & Airlines Key Leaders Conference, held May 12-14 in New York, NY
  • B. Riley Securities 26th Annual Institutional Investor Conference, held May 20-21 in Marina Del Rey, CA



About Bowman Consulting Group Ltd.


Headquartered in Reston, Virginia, Bowman is a national engineering services firm delivering infrastructure, technology and project management solutions to customers who own, develop and maintain the built environment. With over 2,500 employees in more than 100 locations throughout the United States, Bowman provides extensive planning, engineering, geospatial, construction management, commissioning, environmental consulting, land procurement and other technical services to customers operating in a diverse set of regulated end markets. Bowman trades on the Nasdaq under the symbol BWMN. For more information, visit bowman.com or investors.bowman.com.

Investor Relations Contact:

Betsy Patterson
[email protected]



Magnachip Launches 8th-generation Ultra Low-Rss(on) 12V BatteryFET Designed for Smartphone Battery Power Efficiency

Magnachip Launches 8th-generation Ultra Low-Rss(on) 12V BatteryFET Designed for Smartphone Battery Power Efficiency

  • RSS(on) Typ. below 1mΩ — delivering ultra-low on-resistance for battery protection circuits (PCMs)

  • 48% reduction in specific on-resistance (Rsp) and 185% improvement in current density compared to the previous generation

  • Designed to meet next-generation smartphone requirements for ultra-fast charging and high-efficiency battery protection

 

SEOUL, South Korea–(BUSINESS WIRE)–
Magnachip Semiconductor Corporation (NYSE: MX, “Magnachip”) today announced the launch of two new 8th-generation Ultra Low-Ron 12V low-voltage (LV) MOSFETs designed for high-performance smartphone battery protection circuits (PCMs). These new products target next-generation smartphones, where ultra-fast charging and energy efficiency are increasingly critical, and represent an expansion of Magnachip’s product lineup, strengthening its competitiveness in the mobile battery protection FET market. One of them is in mass production and is currently being supplied to a major global smartphone manufacturer, having demonstrated proven performance and reliability.

As smartphones incorporate advanced AI functionalities and increasingly high-performance applications, computational loads are rising, driving the importance of power efficiency and charging performance. As a result, MOSFETs used in battery protection circuits (PCMs) are required to deliver low on-resistance, high current density, and efficient performance within limited board space. In addition, the growing adoption of innovative form factors such as foldable and rollable devices further constrains circuit design space, increasing the importance of enhancing performance within the same footprint while reducing component count.

The new products are designed as main switching devices in smartphone battery protection circuits (PCMs), performing critical functions such as overcharge and over-discharge protection, as well as charge and discharge current control. They offer two key advantages:

First, by significantly reducing on-resistance within the same package size, the products minimize heat generation. For example, the MDWC12D013PERH achieves more than a 50% improvement in on-resistance (Rss(on)) compared to Magnachip’s 7th-generation device of the same size, resulting in a temperature reduction of up to 10°C under identical test conditions. This reduced heat contributes to extended battery life and improved charging stability in smartphones.

Second, enhanced current density and pin-to-pin compatibility enable replacement and integration within existing circuit designs, reducing PCB footprint and the number of FETs required, which helps reduce production costs. This allows manufacturers to utilize the saved space for larger battery capacity or slimmer device designs.

The new products incorporate Magnachip’s 8th-generation technology, utilizing a high-density trench cell structure. They reduce specific on-resistance (Rsp) by approximately 48% and improve current density by approximately 185% compared to the previous generation, achieving RSS(on) Typ. below 1mΩ.

According to Omdia, generative AI has emerged as a key trend in the technology market and is rapidly expanding, driven by the consumer (digital) segment. The market is projected to grow from approximately $7.7 billion in 2022 to $30.4 billion by 2028, with smartphones expected to account for a major share of applications.

In response to these market trends, Magnachip plans to introduce 22V Ultra Low-Ron products within the year, further expanding its LV MOSFET portfolio for high-performance mobile devices.

“Achieving low on-resistance and superior thermal performance within limited space is a key challenge in smartphone battery protection circuit design. Our 8th-generation Ultra Low-Ron 12V LV MOSFET is designed to address these requirements, delivering enhanced efficiency and reliability, and is expected to provide highly competitive technical value in this application. Leveraging our expertise in power semiconductor design and manufacturing, Magnachip will continue to enhance its product competitiveness across a wide range of applications, including mobile,” said Hyuk Woo, CTO of Magnachip Semiconductor.

At PCIM Europe 2026 in Nuremberg, Germany (Hall 6, Booth 337), Magnachip will showcase its power semiconductor solutions, including these new products.

Magnachip’s New 8th-generation LV MOSFETs

Product

VSS [V]

RSS(on) [mΩ] @VGS=3.8V

Package (mm)

Max.

Typ.

MDWS12D012PERH

12

1.2

0.9

WLCSP (3.20 x 1.95)

MDWC12D013PERH

12

1.2

0.9

WLCSP (2.98 x 1.49)

Related Links

Power Solutions > MXT MOSFETs > 12V

Related Articles

Magnachip Unveils Its First 8th-Generation MXT LV MOSFET Designed with Super-Short Channel FET II

Magnachip Launches New 24V BatteryFET for Tri-Fold Smartphone Battery Protection

About Magnachip Semiconductor

Magnachip is a designer and manufacturer of analog and mixed-signal power semiconductor platform solutions for various applications, including industrial, automotive, communication, consumer and computing. The Company provides a broad range of standard products to customers worldwide. Magnachip, with about 45 years of operating history, owns a substantial number of registered patents and pending applications, and has extensive engineering, design and manufacturing process expertise. For more information, please visit www.magnachip.com. Information on or accessible through Magnachip’s website is not a part of, and is not incorporated into, this release.

Mike Bishop

United States (Investor Relations)

Bishop IR, LLC

Tel. +1-415-891-9633

[email protected]

Kyeongah Cho

Global Marketing Communication

Magnachip Semiconductor

Tel. +82-2-6903-3179

[email protected]

KEYWORDS: Germany Europe South Korea Asia Pacific

INDUSTRY KEYWORDS: Semiconductor Technology Batteries Mobile/Wireless Artificial Intelligence Hardware

MEDIA:

Logo
Logo

Tractor Supply Company Reports First Quarter 2026 Financial Results; Reaffirms Fiscal Year 2026 Outlook

Tractor Supply Company Reports First Quarter 2026 Financial Results; Reaffirms Fiscal Year 2026 Outlook

BRENTWOOD, Tenn.–(BUSINESS WIRE)–Tractor Supply Company (NASDAQ: TSCO), the largest rural lifestyle retailer in the United States (the “Company”), today reported financial results for its first quarter ended March 28, 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421543068/en/

  • Net Sales Increased 3.6% to $3.59 Billion

  • Comparable Store Sales Increased 0.5%

  • Diluted Earnings per Share (“EPS”) of $0.31

  • Company Reaffirms Fiscal Year 2026 Outlook, Including Comparable Store Sales Growth of 1% to 3% and Diluted EPS of $2.13 to $2.23

“We delivered solid performance across the majority of our business in the first quarter, supported by our needs-based model and ongoing customer engagement. We continued to gain market share in farm and ranch and had strong double-digit growth in digital sales. Performance was positive across four of our five product categories. While companion animal trailed the Company average, we are taking decisive actions to improve its performance. I want to thank our more than 52,000 Team Members for their ongoing dedication to serving our customers and living our Mission and Values each day,” said Hal Lawton, President and Chief Executive Officer of Tractor Supply.

“We remain confident in our outlook and our ability to drive continued market share gains as our customers remain engaged. The underlying health of Tractor Supply remains strong, supported by a loyal customer base, a differentiated business model and consistent execution.”

First Quarter 2026 Results

Net sales for the first quarter of 2026 increased 3.6% to $3.59 billion from $3.47 billion in the first quarter of 2025. The increase in net sales was driven by robust new store openings and, to a lesser extent, growth in comparable store sales. Comparable store sales increased 0.5% compared to a decrease of 0.9% in the prior year’s first quarter. Comparable average ticket increased 1.6%, partially offset by a comparable average transaction count decrease of 1.0%. The Company delivered strong double-digit growth in digital sales. Four of five product categories delivered positive comparable sales growth in the quarter, complemented by strength in big ticket items. Companion animal performance was below the Company average, reflecting softer demand trends, category shifts and an unfavorable product mix.

Gross profit increased 3.6% to $1.30 billion from $1.26 billion in the prior year’s first quarter, and gross margin was flat with the prior year at 36.2%. The gross margin rate benefited from disciplined product cost management and the continued execution of an everyday low price strategy, offset by higher tariffs and delivery-related transportation costs.

Selling, general and administrative (“SG&A”) expenses, including depreciation and amortization, increased 6.1% to $1.07 billion from $1.01 billion in the prior year’s first quarter. As a percent of net sales, SG&A expenses increased 70 basis points to 29.7% from 29.0% in the first quarter of 2025. The increase in SG&A, as a percent of net sales, was primarily attributable to deleverage of fixed costs given the comparable store sales performance and an accelerated new store opening cadence, partially offset by an ongoing focus on productivity and cost discipline.

Operating income decreased 6.3% to $233.4 million from $249.1 million in the first quarter of 2025.

The effective income tax rate was 23.2% compared to 21.8% in the first quarter of 2025. The effective tax rate for the prior year’s first quarter was impacted by the timing of discrete items.

Net income decreased 8.3% to $164.5 million from $179.4 million in the prior year’s first quarter. Diluted EPS decreased 7.2% to $0.31 compared to $0.34.

The Company repurchased approximately 2.3 million shares of its common stock for $118.0 million and paid quarterly cash dividends totaling $126.4 million, returning a total of $244.4 million of capital to shareholders in the first quarter of 2026.

The Company opened 40 new Tractor Supply stores and closed one Petsense by Tractor Supply store in the first quarter of 2026.

Fiscal Year 2026 Financial Outlook

Based on year-to-date performance and its outlook, Tractor Supply reiterates the following financial guidance for fiscal year 2026, initially provided on January 29, 2026:

 

Outlook

Net Sales

+4% to +6%

Comparable Store Sales

+1% to +3%

Operating Margin Rate

9.3% to 9.6%

Net Income

$1.11 billion to $1.17 billion

Earnings per Diluted Share

$2.13 to $2.23

Conference Call Information

Tractor Supply Company will hold a conference call today, Tuesday, April 21, 2026 at 10 a.m. ET. The call will be webcast live at IR.TractorSupply.com.

Please allow extra time prior to the call to visit the site and download the streaming media software required to access the webcast.

A replay of the webcast will also be available at IR.TractorSupply.com shortly after the call concludes.

About Tractor Supply Company

For more than 85 years, Tractor Supply Company (NASDAQ: TSCO) has been passionate about serving the needs of recreational farmers, ranchers, homeowners, gardeners, pet enthusiasts and all those who enjoy living Life Out Here. Tractor Supply is the largest rural lifestyle retailer in the U.S., ranking 296 on the Fortune 500. The Company’s more than 52,000 Team Members are known for delivering legendary service and helping customers pursue their passions, whether that means being closer to the land, taking care of animals or living a hands-on, DIY lifestyle. In store and online, Tractor Supply provides what customers need – anytime, anywhere, any way they choose at the low prices they deserve.

As part of the Company’s commitment to caring for animals of all kinds, Tractor Supply is proud to include Petsense by Tractor Supply, a pet specialty retailer, and Allivet, a leading online pet and animal pharmacy, in its family of brands. Together, Tractor Supply is able to provide comprehensive solutions for pet care, livestock wellness and rural living, ensuring customers and their animals thrive. From its stores to the customer’s doorstep, Tractor Supply is here to serve and support Life Out Here.

As of March 28, 2026, the Company operated 2,435 Tractor Supply stores in 49 states and 206 Petsense by Tractor Supply stores in 23 states. For more information, visit www.tractorsupply.com and www.Petsense.com.

Forward-Looking Statements

This press release contains certain forward-looking statements, including statements regarding market share gains, value creation, customer trends, new stores and distribution centers, property development plans, return of capital, financial guidance for fiscal 2026, including net sales, comparable store sales, operating margin rates, net income and earnings per diluted share. All forward-looking statements are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, are subject to the finalization of the Company’s quarterly financial and accounting procedures, and may be affected by certain risks and uncertainties, any one, or a combination, of which could materially affect the results of the Company’s operations. Forward-looking statements are usually identified by or are associated with such words as “will,” “intend,” “would,” “expect,” “continue,” “believe,” “anticipate,” “optimistic,” “forecasted” and similar terminology. Actual results could vary materially from the expectations reflected in these statements. As with any business, all phases of our operations are subject to facts outside of our control. These factors include, without limitation, the impact of the recent and potential future tariff announcements and the corresponding macroeconomic pressures and those factors discussed in the “Risk Factors” section of the Company’s Annual Reports or Form 10-K and other filings with the Securities and Exchange Commission. Forward-looking statements made by or on behalf of the Company are based on knowledge of its business and the environment in which it operates, but because of the factors listed above, actual results could differ materially from those reflected by any forward-looking statements. Consequently, all of the forward-looking statements made are qualified by these cautionary statements and those contained in the Company’s most recent Annual Report on Form 10-K, quarterly reports on Form 10-Q, and other filings with the Securities and Exchange Commission. There can be no assurance that the results or developments anticipated by the Company will be realized or, even if substantially realized, that they will have the expected consequences to or effects on the Company or its business and operations. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to release publicly any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

(Financial tables to follow)

Consolidated Statements of Income

(Unaudited)

(in thousands, except per share and percentage data)

 

For the Fiscal Three

 

Months Ended

 

March 28,

2026

 

March 29,

2025

 

 

 

% of

 

 

 

% of

 

 

 

Net

 

 

 

Net

 

 

 

Sales

 

 

 

Sales

Net sales

$

3,592,046

 

100.00

%

 

$

3,466,952

 

100.00

%

Cost of merchandise sold

 

2,290,861

 

63.78

 

 

 

2,211,530

 

63.79

 

Gross profit

 

1,301,185

 

36.22

 

 

 

1,255,422

 

36.21

 

Selling, general and administrative expenses

 

941,153

 

26.20

 

 

 

886,206

 

25.56

 

Depreciation and amortization

 

126,601

 

3.52

 

 

 

120,079

 

3.46

 

Operating income

 

233,431

 

6.50

 

 

 

249,137

 

7.19

 

Interest expense, net

 

19,108

 

0.53

 

 

 

19,641

 

0.57

 

Income before income taxes

 

214,323

 

5.97

 

 

 

229,496

 

6.62

 

Income tax expense

 

49,799

 

1.39

 

 

 

50,127

 

1.45

 

Net income

$

164,524

 

4.58

%

 

$

179,369

 

5.17

%

 

 

 

 

 

 

 

 

Net income per share – basic

$

0.31

 

 

 

$

0.34

 

 

Net income per share – diluted

$

0.31

 

 

 

$

0.34

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

Basic

 

526,327

 

 

 

 

531,730

 

 

Diluted

 

528,136

 

 

 

 

534,099

 

 

 

 

 

 

 

 

 

 

Dividends declared per common share outstanding

$

0.24

 

 

 

$

0.23

 

 

 

Note: Percent of net sales amounts may not sum to totals due to rounding.

Consolidated Statements of Comprehensive Income

(Unaudited)

(in thousands)

 

 

For the Fiscal Three

 

Months Ended

 

March 28,

2026

 

 

March 29,

2025

Net income

$

164,524

 

 

$

179,369

 

Other comprehensive loss:

 

 

 

 

Change in fair value of interest rate swaps, net of taxes

 

 

 

 

(1,217

)

Total other comprehensive loss

 

 

 

 

(1,217

)

Total comprehensive income

$

164,524

 

 

$

178,152

 

 

Consolidated Balance Sheets

(Unaudited)

(in thousands)

 

 

March 28,

2026

 

March 29,

2025

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

224,269

 

 

$

231,717

 

Inventories

 

3,583,601

 

 

 

3,213,885

 

Prepaid expenses and other current assets

 

222,440

 

 

 

210,480

 

Income taxes receivable

 

11,286

 

 

 

 

Total current assets

 

4,041,596

 

 

 

3,656,082

 

Property and equipment, net

 

3,132,326

 

 

 

2,752,137

 

Operating lease right-of-use assets

 

4,031,692

 

 

 

3,502,880

 

Goodwill and other intangible assets

 

398,213

 

 

 

400,656

 

Other assets

 

58,270

 

 

 

73,562

 

Total assets

$

11,662,097

 

 

$

10,385,317

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

1,760,426

 

 

$

1,559,210

 

Accrued employee compensation

 

20,977

 

 

 

17,487

 

Other accrued expenses

 

674,003

 

 

 

587,800

 

Current portion of finance lease liabilities

 

7,128

 

 

 

2,847

 

Current portion of operating lease liabilities

 

455,159

 

 

 

403,600

 

Income taxes payable

 

12,028

 

 

 

29,570

 

Total current liabilities

 

2,929,721

 

 

 

2,600,514

 

Long-term debt

 

2,125,726

 

 

 

2,082,721

 

Finance lease liabilities, less current portion

 

35,157

 

 

 

24,289

 

Operating lease liabilities, less current portion

 

3,785,608

 

 

 

3,248,270

 

Deferred income taxes

 

113,354

 

 

 

41,649

 

Other long-term liabilities

 

158,782

 

 

 

149,334

 

Total liabilities

 

9,148,348

 

 

 

8,146,777

 

 

 

 

 

Stockholders’ equity:

 

 

 

Common stock

 

7,134

 

 

 

7,123

 

Additional paid-in capital

 

1,454,387

 

 

 

1,382,807

 

Treasury stock

 

(6,505,040

)

 

 

(6,119,065

)

Accumulated other comprehensive income

 

 

 

 

 

Retained earnings

 

7,557,268

 

 

 

6,967,675

 

Total stockholders’ equity

 

2,513,749

 

 

 

2,238,540

 

Total liabilities and stockholders’ equity

$

11,662,097

 

 

$

10,385,317

 

 

Consolidated Statements of Cash Flows

(Unaudited)

(in thousands)

 

For the Fiscal Three Months Ended

 

March 28,

2026

 

March 29,

2025

Cash flows from operating activities:

 

 

 

Net income

$

164,524

 

 

$

179,369

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation and amortization

 

126,601

 

 

 

120,079

 

Gain on disposition of property and equipment

 

(22,741

)

 

 

(17,415

)

Share-based compensation expense

 

17,631

 

 

 

13,226

 

Deferred income taxes

 

23,501

 

 

 

1,677

 

Change in assets and liabilities:

 

 

 

Inventories

 

(499,515

)

 

 

(355,486

)

Prepaid expenses and other current assets

 

(19,953

)

 

 

(11,320

)

Accounts payable

 

369,593

 

 

 

311,807

 

Accrued employee compensation

 

(93,864

)

 

 

(83,666

)

Other accrued expenses

 

(11,047

)

 

 

2,609

 

Income taxes

 

27,787

 

 

 

46,526

 

Other

 

8,603

 

 

 

9,369

 

Net cash provided by operating activities

 

91,120

 

 

 

216,775

 

Cash flows from investing activities:

 

 

 

Capital expenditures

 

(202,610

)

 

 

(141,280

)

Proceeds from sale of property and equipment

 

31,274

 

 

 

20,851

 

Acquisition of Allivet, net of cash acquired

 

 

 

 

(140,625

)

Net cash used in investing activities

 

(171,336

)

 

 

(261,054

)

Cash flows from financing activities:

 

 

 

Borrowings under debt facilities

 

1,480,000

 

 

 

605,000

 

Repayments under debt facilities

 

(1,120,000

)

 

 

(355,000

)

Principal payments under finance lease liabilities

 

(717

)

 

 

(1,068

)

Repurchase of shares to satisfy tax obligations

 

(14,102

)

 

 

(13,960

)

Repurchase of common stock

 

(118,019

)

 

 

(95,082

)

Net proceeds from issuance of common stock

 

9,595

 

 

 

7,016

 

Cash dividends paid to stockholders

 

(126,381

)

 

 

(122,401

)

Net cash provided by financing activities

 

110,376

 

 

 

24,505

 

Net increase (decrease) in cash and cash equivalents

 

30,160

 

 

 

(19,774

)

Cash and cash equivalents at beginning of period

 

194,109

 

 

 

251,491

 

Cash and cash equivalents at end of period

$

224,269

 

 

$

231,717

 

 

Selected Financial and Operating Information

(Unaudited)

 

 

For the Fiscal Three

 

Months Ended

 

March 28,

2026

 

March 29,

2025

Sales Information:

 

 

 

Comparable store sales increase/(decrease)

 

0.5

%

 

 

(0.9

)%

New store sales (% of total sales)

 

3.1

%

 

 

2.8

%

Average transaction value

$

57.71

 

 

$

56.87

 

Comparable store average transaction value increase/(decrease) (a)

 

1.6

%

 

 

(2.9

)%

Comparable store average transaction count increase/(decrease)

 

(1.0

)%

 

 

2.1

%

Total selling square footage (000’s)

 

41,438

 

 

 

39,353

 

Owned Brands and Exclusive Product Categories (% of total sales) (b)

 

31.8

%

 

 

30.9

%

Imports (% of total sales)

 

10.6

%

 

 

11.2

%

 

 

 

 

Store Count Information:

 

 

 

Tractor Supply

 

 

 

Beginning of period

 

2,395

 

 

 

2,296

 

New stores opened

 

40

 

 

 

15

 

Stores closed

 

 

 

 

 

End of period

 

2,435

 

 

 

2,311

 

Petsense by Tractor Supply

 

 

 

Beginning of period

 

207

 

 

 

206

 

New stores opened

 

 

 

 

2

 

Stores closed

 

(1

)

 

 

(2

)

End of period

 

206

 

 

 

206

 

Consolidated end of period

 

2,641

 

 

 

2,517

 

 

 

 

 

Pre-opening costs (000’s)

$

4,284

 

 

$

2,512

 

 

 

 

 

Balance Sheet Information:

 

 

 

Average inventory per store (000’s) (c)

$

1,278.3

 

 

$

1,202.1

 

Inventory turns (annualized)

 

2.92

 

 

 

3.00

 

 

 

 

 

Share repurchase program:

 

 

 

Cost (000’s) (d)

$

118,811

 

 

$

93,827

 

Average purchase price per share

$

50.75

 

 

$

54.39

 

 

(a) Comparable store average transaction value changes include the impact of transaction value changes achieved on the current period change in transaction count.

(b) Beginning in the fiscal year ended December 27, 2025, the metric of exclusive brands as a percentage of total sales, which historically included only Tractor Supply Owned Brands, was revised to include both Tractor Supply Owned Brands and Exclusive Product Categories as a percentage of total sales. Prior period amounts have been recast to conform to the current year presentation.

(c) Assumes average inventory cost, excluding inventory in transit.

(d) Effective January 1, 2023, the Company’s share repurchases are subject to a 1% excise tax as a result of the Inflation Reduction Act of 2022. Excise taxes incurred on share repurchases represent direct costs of the repurchase and are recorded as a part of the cost basis of the shares within treasury stock.

 

Note: Comparable store metrics percentages may not sum to total due to rounding.

 

 

For the Fiscal Three

 

Months Ended

 

March 28,

2026

 

March 29,

2025

Capital Expenditures (in millions):

 

 

 

New stores, relocated stores and stores not yet opened

$

93.7

 

$

59.5

Existing stores

 

52.6

 

 

43.0

Information technology

 

34.1

 

 

26.0

Distribution center capacity and improvements

 

22.0

 

 

8.0

Corporate and other

 

0.2

 

 

4.8

Total

$

202.6

 

$

141.3

 

Mary Winn Pilkington (615) 440-4212

Rena Clayton Rolfe (615) 647-1561

[email protected]

KEYWORDS: Tennessee United States North America

INDUSTRY KEYWORDS: Retail Consumer Agriculture Specialty Pets Natural Resources

MEDIA:

Logo
Logo